证券代码：688371 证券简称：菲沃泰 公告编号：2025-046 江苏菲沃泰纳米科技股份有限公司 关于参加 2025 无锡上市公司投资者集体接待日活动 二、说明会召开的时间、地点 会议召开时间：2025 年 11 月 4 日(星期二)下午 15:30-17:00 会议召开地点："全景路演"网站（http://rs.p5w.net） 会议召开方式：网络文字互动 （一）会议召开时间：2025 年 11 月 4 日(星期二)下午 15:30-17:00 （二）会议召开地点："全景路演"网站（http://rs.p5w.net） 暨召开 2025 年第三季度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 投资者可于 2025 年 11 月 4 日(星期二)下午 15:30-17:00 登录"全景路演" （http://rs.p5w.net），或关注微信公众号：全景财经，或下载全景路演 APP，参 与本次互动交流；也可于 2025 年 11 月 3 日(星期一)16:00 前将需要了解和关注 的问题 ...

Market Overview - The electronic chemicals sector experienced a decline of 0.3% on October 28, with Siquan New Materials leading the drop [1] - The Shanghai Composite Index closed at 3988.22, down 0.22%, while the Shenzhen Component Index closed at 13430.1, down 0.44% [1] Stock Performance - Notable gainers in the electronic chemicals sector included: - Huate Gas (688268) with a closing price of 68.52, up 5.42% on a trading volume of 44,800 shares and a turnover of 297 million [1] - Jingrui Electric Materials (300655) closed at 18.25, up 4.23% with a trading volume of 3.09 million shares and a turnover of 56.791 million [1] - Conversely, Siquan New Materials (301489) saw a significant decline of 16.98%, closing at 203.30 with a trading volume of 138,900 shares and a turnover of 298.5 million [2] Capital Flow - The electronic chemicals sector experienced a net outflow of 1.446 billion in main funds, while retail investors saw a net inflow of 1.253 billion [2] - The capital flow for specific stocks showed: - Dinglong Co. (300054) had a main fund net inflow of 37.85 million, but retail investors had a net outflow of 22.91 million [3] - Huate Gas (688268) experienced a main fund net inflow of 8.2143 million, with retail investors seeing a net outflow of 8.6272 million [3]

Core Insights - Favored Tech Corporation Limited (菲沃泰) reported its Q3 2025 financial results, revealing that as of October 24, 2025, seven institutional investors held a total of 233 million shares, representing 69.41% of the company's total equity [1] - The institutional ownership percentage decreased by 3.22 percentage points compared to the previous quarter [1] Institutional Investors - The institutional investors include Favored Tech Corporation Limited, Wuxi Fina Enterprise Management Partnership, Shenzhen China Resources Capital Equity Investment, China Construction Bank's Guoshou Anbao Smart Life Fund, Qingdao Yirong United Equity Investment Management Center, Shanghai Fuhe Private Fund Management, and Beijing Woyan Capital Management Center [1] - The total institutional ownership is significant, indicating strong interest from major investment entities [1] Public Funds - In this reporting period, 89 public funds were disclosed, including notable funds such as Southern Zhihong Mixed A, Guotai Shanghai Composite ETF, and Jianxin Shanghai Composite Smart Selection Sci-Tech Innovation Value ETF [1] - The absence of previously disclosed public funds suggests a shift in investment strategies or market conditions [1]

Core Viewpoint - The company has announced the approval of several key resolutions during its board meetings, including the appointment of a new secretary and financial director, the approval of the third-quarter report, and the decision to permanently supplement working capital with surplus funds from fundraising projects [9][11][13][19]. Financial Data - The third-quarter financial report for 2025 has been prepared, but it has not been audited [3][13]. - The company reported a surplus of 52.03 million yuan from its fundraising projects, which will be used to enhance working capital [28][30]. Shareholder Information - The company has a total of 9,681,336 shares held by its repurchase account, accounting for 2.89% of the total share capital [6]. - The board has approved the cancellation of stock options related to the 2024 stock option incentive plan due to the departure of one incentive object [17][39]. Board Meeting Details - The second board meeting was held on October 24, 2025, with all nine directors present, and the meeting followed legal and regulatory procedures [10][12]. - The board approved the appointment of Zhao Qianbo as the new secretary and financial director, effective immediately [11][45]. Fund Management - The company has established a management system for the use of raised funds, ensuring compliance with relevant laws and regulations [25]. - The surplus funds from the fundraising projects will be permanently added to the company's working capital, with the necessary procedures for account cancellation to follow [19][30].

Core Viewpoint - The company reported a revenue of 138 million yuan in the third quarter, reflecting a year-on-year growth of 4.47% [1] - The net profit attributable to shareholders was 12.26 million yuan, showing a year-on-year increase of 4.74% [1] - The net profit after deducting non-recurring gains and losses was 2.69 million yuan, which represents a significant year-on-year decline of 70.49% [1] - The basic earnings per share stood at 0.04 yuan [1] Financial Performance - Third quarter revenue reached 138 million yuan, up 4.47% year-on-year [1] - Net profit attributable to shareholders was 12.26 million yuan, an increase of 4.74% year-on-year [1] - Net profit excluding non-recurring items was 2.69 million yuan, down 70.49% year-on-year [1] - Basic earnings per share recorded at 0.04 yuan [1]

证券代码：688371 证券简称：菲沃泰 公告编号：2025-044 江苏菲沃泰纳米科技股份有限公司 关于注销 2024 年股票期权激励计划部分股票期权 的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 江苏菲沃泰纳米科技股份有限公司（以下简称"公司"）于 2025 年 10 月 23 日、2025 年 10 月 24 日分别召开了第二届董事会薪酬与考核委员会第八次会 议、第二届董事会第十六次会议，审议通过了《关于注销 2024 年股票期权激励 计划部分股票期权的议案》，现将有关情况公告如下： 一、已履行的相关审批程序和信息披露情况 1、2024 年 9 月 9 日，公司召开第二届董事会第八次会议，审议通过了《关 于<公司 2024 年股票期权激励计划（草案）>及其摘要的议案》《关于<公司 2024 年股票期权激励计划实施考核管理办法>的议案》及《关于提请股东大会授权董 事会办理公司股票期权激励计划相关事宜的议案》等议案。 同日，公司召开第二届监事会第六次会议，审议通过了《关于<公司 2024 年股票期权激励计划（草 ...

Group 1 - The company announced the resignation of Mr. Zong Jian and Mr. Sun Xilin from their positions as Chief Financial Officer and Secretary of the Board, respectively, due to work adjustments [1] - To enhance internal operational management efficiency, the company appointed Ms. Zhao Qianbo as the new Secretary of the Board and Chief Financial Officer after a thorough review process [1] - For the fiscal year 2024, the company's revenue composition is projected to be 93.95% from manufacturing and 6.05% from other businesses [1] Group 2 - The company's market capitalization is currently valued at 8 billion yuan [2] - The Chinese innovative drug sector has generated 80 billion USD in overseas licensing deals this year, indicating a robust secondary market for biopharmaceuticals [2]

Group 1 - The core viewpoint of the article highlights the financial performance of Fivotech, with a revenue of approximately 367 million yuan for the first three quarters of 2025, representing a year-on-year increase of 6% [1] - The net profit attributable to shareholders for the same period is about 28.98 million yuan, showing a year-on-year growth of 6.45% [1] - As of the report date, Fivotech's market capitalization stands at 8 billion yuan [2] Group 2 - The article discusses the broader context of the Chinese innovative drug market, noting that overseas licensing has generated 80 billion USD this year [2] - It raises questions about the disparity between the hot secondary market for biomedicine and the cooling fundraising environment in the primary market [2]

流动资金的核查意见 中国国际金融股份有限公司（以下简称"中金公司"或"保荐机构"）作为 江苏菲沃泰纳米科技股份有限公司（以下简称"菲沃泰"或"公司"）的保荐机 构，根据《上市公司募集资金监管规则》《上海证券交易所科创板上市公司自律 监管指引第 1 号——规范运作》等有关法律、行政法规、部门规章及业务规则的 要求，对菲沃泰本次注销募集资金专户及节余募集资金永久补充流动资金事项进 行了认真、审慎核查，具体情况如下： 一、募集资金基本情况 经中国证券监督管理委员会证监许可[2022]1078 号《关于同意江苏菲沃泰纳 米科技股份有限公司首次公开发行股票注册的批复》，同意公司首次公开发行股 票的注册申请，公司向社会公开发行人民币普通股（A 股）股票 83,868,089 股 （每股面值人民币 1 元），每股发行价 18.54 元/股，募集资金总额 1,554,914,370.06 元，扣除不含税的发行费用人民币 118,528,277.06 元，实际募集资金净额为 1,436,386,093.00 元。立信会计师事务所（特殊普通合伙）于 2022 年 7 月 28 日 对本次发行的募集资金到位情况进行了审验，并出具了 ...

北京市中伦律师事务所 关于江苏菲沃泰纳米科技股份有限公司 注销 2024 年股票期权激励计划部分股票期权的 法律意见书 2025 年 10 月 北京 ・ 上海 ・ 深圳 ・ 广州 ・ 武汉 ・ 成都 ・ 重庆 ・ 青岛 ・ 杭州 ・ 南京 ・ 海口 ・ 东京 ・ 香港 ・ 伦敦 ・ 纽约 ・ 洛杉矶 ・ 旧金山 ・ 阿拉木图 Beijing • Shangha • Shenzhen • Guangzhou • Wuhan • Chengdu • Changzhou • Nangzhou • Nangzhou • Nangzhou • Nangzhou • Nangzhou • Almatyso • London • New York • Los Angeles • 北京市朝阳区金和东路20号 22-31/F, South Tower of CP Center, 20 Jin He East A Beijing 100020, P.R. China 申话/Tel : +86 10 5957 2288 传真/Fax : +86 10 6568 北京市中伦律师事务所 关于江苏菲沃泰纳米科技股份有限公司 注销 202 ...